HU208147B - Process for producing etoposide-aminophosphate derivatives - Google Patents

Process for producing etoposide-aminophosphate derivatives

Info

Publication number
HU208147B
HU208147B HU905862A HU586288A HU208147B HU 208147 B HU208147 B HU 208147B HU 905862 A HU905862 A HU 905862A HU 586288 A HU586288 A HU 586288A HU 208147 B HU208147 B HU 208147B
Authority
HU
Hungary
Prior art keywords
aminophosphate
derivatives
etoposide
producing
producing etoposide
Prior art date
Application number
HU905862A
Other languages
English (en)
Hungarian (hu)
Other versions
HU905862D0 (en
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HU905862D0 publication Critical patent/HU905862D0/hu
Publication of HU208147B publication Critical patent/HU208147B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
HU905862A 1987-08-04 1988-08-03 Process for producing etoposide-aminophosphate derivatives HU208147B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (2)

Publication Number Publication Date
HU905862D0 HU905862D0 (en) 1991-03-28
HU208147B true HU208147B (en) 1993-08-30

Family

ID=26765636

Family Applications (3)

Application Number Title Priority Date Filing Date
HU905862A HU208147B (en) 1987-08-04 1988-08-03 Process for producing etoposide-aminophosphate derivatives
HU884081A HU202547B (en) 1987-08-04 1988-08-03 Process for producing epipodophyllotoxin-glycoside-4'-phosphate derivatives and pharmaceutical compositions comprising such active ingredient
HU95P/P00387P HU211960A9 (en) 1987-08-04 1995-06-22 Epipodophyllotoxinglucosid-4'-phosphat-derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU884081A HU202547B (en) 1987-08-04 1988-08-03 Process for producing epipodophyllotoxin-glycoside-4'-phosphate derivatives and pharmaceutical compositions comprising such active ingredient
HU95P/P00387P HU211960A9 (en) 1987-08-04 1995-06-22 Epipodophyllotoxinglucosid-4'-phosphat-derivatives

Country Status (34)

Country Link
US (3) US4904768A (https=)
JP (1) JPH0699465B2 (https=)
KR (1) KR900006230B1 (https=)
CN (1) CN1027169C (https=)
AT (1) AT398974B (https=)
BE (1) BE1002982A4 (https=)
CA (1) CA1310637C (https=)
CH (1) CH676716A5 (https=)
CY (1) CY1625A (https=)
CZ (1) CZ286893B6 (https=)
DD (2) DD299067A5 (https=)
DE (1) DE3826562A1 (https=)
DK (2) DK169344B1 (https=)
ES (1) ES2010775A6 (https=)
FI (1) FI87790C (https=)
FR (1) FR2622193B1 (https=)
GB (1) GB2207674B (https=)
GR (1) GR1000490B (https=)
HK (1) HK6392A (https=)
HU (3) HU208147B (https=)
IE (1) IE61040B1 (https=)
IL (1) IL87290A (https=)
IT (1) IT1226825B (https=)
LU (2) LU87290A1 (https=)
MX (1) MX173843B (https=)
MY (1) MY104321A (https=)
NL (2) NL192683C (https=)
NO (4) NO170284C (https=)
NZ (1) NZ225615A (https=)
PT (1) PT88186B (https=)
SE (1) SE502214C2 (https=)
SG (1) SG101291G (https=)
SK (1) SK279325B6 (https=)
YU (3) YU143688A (https=)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (https=) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JPH07632B2 (ja) * 1991-12-23 1995-01-11 ブリストル−マイヤーズ スクイブ カンパニー エトポシド４’−ホスフェート二ナトリウム塩の安定な六水和物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
EP0835303A4 (en) * 1995-06-07 2000-09-13 Univ Jefferson Anti-fungal agents and methods of identifying and using the same
AU726914B2 (en) * 1996-04-01 2000-11-23 Epix Pharmaceuticals, Inc. Bioactivated diagnostic imaging contrast agents
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
EP1438319A1 (en) * 2001-10-26 2004-07-21 Centre National De La Recherche Scientifique (Cnrs) Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
KR20120068769A (ko) 2002-07-15 2012-06-27 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
WO2004060403A2 (en) * 2003-01-06 2004-07-22 Angiochem Inc. Aprotinin and anglos as carriers across the blood-brain barrier
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
RU2408605C2 (ru) * 2005-02-18 2011-01-10 Анджиокем Инк. Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
ES2744225T3 (es) 2005-07-15 2020-02-24 Angiochem Inc Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8263644B2 (en) * 2007-09-13 2012-09-11 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
CA2705152C (en) 2007-11-09 2016-10-11 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
EP2240475B1 (en) 2007-12-20 2013-09-25 Novartis AG Thiazole derivatives used as pi 3 kinase inhibitors
MX355683B (es) * 2008-04-18 2018-04-26 Angiochem Inc Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
WO2010043049A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
CA2740316A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
CA2745524C (en) * 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
US8853353B2 (en) 2008-12-17 2014-10-07 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
MX2011011023A (es) 2009-04-20 2012-01-20 Angiochem Inc Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
EP2539337A1 (en) 2010-02-22 2013-01-02 F. Hoffmann-La Roche AG Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
MX343706B (es) 2011-01-31 2016-11-18 Novartis Ag Derivados heterocíclicos novedosos.
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
PT2771342T (pt) 2011-10-28 2016-08-17 Novartis Ag Derivados de purina e o seu uso no tratamento de doença
CA2855994A1 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
WO2013173283A1 (en) 2012-05-16 2013-11-21 Novartis Ag Dosage regimen for a pi-3 kinase inhibitor
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
CN105979947A (zh) 2013-12-06 2016-09-28 诺华股份有限公司 α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
RU2018119085A (ru) 2015-11-02 2019-12-04 Новартис Аг Схема введения ингибитора фосфатидилинозитол-3-киназы
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (https=) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH544752A (de) * 1966-12-13 1974-01-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
IE61040B1 (en) 1994-09-07
JPH0699465B2 (ja) 1994-12-07
FI883596A7 (fi) 1989-02-05
CZ541288A3 (cs) 1999-12-15
SK541288A3 (en) 1998-10-07
MY104321A (en) 1994-03-31
NL192683B (https=) 1997-08-01
US4904768A (en) 1990-02-27
NL192683C (nl) 1997-12-02
IL87290A (en) 1993-01-31
NO170284C (no) 1992-09-30
NO170284B (no) 1992-06-22
DK169344B1 (da) 1994-10-10
DK434088A (da) 1989-02-05
NL8801934A (nl) 1989-03-01
CZ286893B6 (cs) 2000-07-12
DE3826562C2 (https=) 1993-04-08
KR900006230B1 (ko) 1990-08-27
MX173843B (es) 1994-03-30
DE3826562A1 (de) 1989-02-16
US5041424A (en) 1991-08-20
GR1000490B (el) 1992-07-30
IT8821535A0 (it) 1988-07-28
KR890003790A (ko) 1989-04-18
AT398974B (de) 1995-02-27
HK6392A (en) 1992-01-17
SE502214C2 (sv) 1995-09-18
NO883299D0 (no) 1988-07-26
IT1226825B (it) 1991-02-19
FI883596A0 (fi) 1988-08-01
IE882378L (en) 1989-02-04
CN1027169C (zh) 1994-12-28
NL970042I2 (https=) 2005-06-01
ATA195588A (de) 1994-07-15
PT88186A (pt) 1989-06-30
CY1625A (en) 1992-07-10
SK279325B6 (sk) 1998-10-07
NO920665L (no) 1989-02-24
NO172440B (no) 1993-04-13
YU10490A (en) 1990-06-30
FR2622193A1 (fr) 1989-04-28
NO920277L (no) 1989-02-24
FI87790C (fi) 1993-02-25
DK434088D0 (da) 1988-08-03
JPH01100188A (ja) 1989-04-18
GB8818462D0 (en) 1988-09-07
HU211960A9 (en) 1996-01-29
NO172440C (no) 1993-07-21
SG101291G (en) 1992-01-17
USRE35524E (en) 1997-06-03
GB2207674A (en) 1989-02-08
HU202547B (en) 1991-03-28
AU610619B2 (en) 1991-05-23
ES2010775A6 (es) 1989-12-01
NL970042I1 (nl) 1998-03-02
FI87790B (fi) 1992-11-13
AU2030688A (en) 1989-06-08
IL87290A0 (en) 1989-01-31
SE8802815L (sv) 1989-02-05
YU143688A (en) 1990-04-30
HU905862D0 (en) 1991-03-28
SE8802815D0 (sv) 1988-08-03
MX9202851A (es) 1992-06-30
BE1002982A4 (fr) 1991-10-15
PT88186B (pt) 1995-07-03
NO920277D0 (no) 1992-01-22
HUT47303A (en) 1989-02-28
DK11992D0 (da) 1992-01-31
NO920665D0 (no) 1992-02-20
GR880100512A (en) 1989-05-25
CA1310637C (en) 1992-11-24
GB2207674B (en) 1991-09-11
LU87290A1 (fr) 1990-02-07
DD274423A5 (de) 1989-12-20
NO883299L (no) 1989-02-24
DD299067A5 (de) 1992-03-26
FR2622193B1 (fr) 1993-12-17
CH676716A5 (https=) 1991-02-28
LU90138I2 (fr) 1997-11-26
NZ225615A (en) 1991-06-25
YU10390A (en) 1990-06-30
NO1998002I1 (no) 1998-01-14
CN1061225A (zh) 1992-05-20
DK11992A (da) 1992-01-31

Similar Documents

Publication Publication Date Title
HU208147B (en) Process for producing etoposide-aminophosphate derivatives
HUT47644A (en) Process for producing avermeklin b derivatives
HU902447D0 (en) Process for producing amino-triazinones
HU46335A (en) Process for producing 4-demethoxy-4-amino-anthracycline derivatives
HUT46672A (en) Process for producing 9-amino-tetrahydroacridine derivatives
HUT48245A (en) Process for producing imidazo-pyridin derivatives
HUT48684A (en) Process for producing avermektin derivatives
HUT45241A (en) Process for producing naphthothiazepinone derivatives
HUT46029A (en) Process for producing inosose derivatives
HUT47866A (en) Process for producing micoplasma-vaccine
HUT47074A (en) Improved process for producing 1-amino-indane derivatives
EP0268820A3 (en) Process for producing 2-acylfuran derivatives
YU192288A (en) Process for preparing quinolynic derivatives
HUT48896A (en) Process for producing acyl-derivatives
HUT48637A (en) Process for producing sialocyl-glycerolipides
EP0289942A3 (en) Process for producing fluorobenzaldehydes
YU112188A (en) Process for preparing 2-metoximethylpenem derivatives
HUT49854A (en) Process for producing 5-amino-1-phenyl-4-nitropyrazole derivatives
HUT53360A (en) Process for producing benzoxazolon derivatives
HUT52489A (en) Process for producing cycloalkyl-thiazol derivatives
HUT49108A (en) Process for producing substituted phenylacetaldehydes
HUT48639A (en) Process for producing 4-demetoxy-antracyclin derivatives
HUT46035A (en) Process for producing 16-dehydro-20-oxopregnane derivatives
HU905041D0 (en) Process for producing 3-fluoro-4-amino-phenol
HU906449D0 (en) Process for producing substituted phenyl-acetonitryl derivatives